Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

Neuvonen, Pertti J., Jalava, Kirsi-Maija · 1996 · Clinical Pharmacology & Therapeutics

Abstract

BACKGROUND: Lovastatin is a cholesterol-lowering drug that can cause myopathy as a rare side effect. Concomitant use of certain drugs (e.g., cyclosporine) increases the risk of skeletal muscle toxicity. Lovastatin is metabolized by CYP3A4. Because itraconazole is a potent inhibitor of CYP3A4, we wanted to study a possible interaction between these drugs. METHODS: In this double-blind, randomized, two-phase crossover study, 12 healthy volunteers received either 200 mg itraconazole or placebo orally once a day for 4 days. On day 4, each subject ingested a single 40 mg dose of lovastatin. Plasma concentrations of lovastatin, lovastatin acid, itraconazole, hydroxyitraconazole, and creatine kinase were measured up to 24 hours. RESULTS: On average, itraconazole increased the peak concentration (Cmax) of lovastatin and the area under the lovastatin concentration-time curve (AUC) more than twentyfold (p < 0.001). The mean Cmax of the active metabolite, lovastatin acid, was increased 13-fold (range, tenfold to 23-fold; p < 0.001) and the AUC(0-24) twentyfold (p < 0.001). In one subject plasma creatine kinase was increased tenfold within 24 hours of lovastatin administration during the itraconazole phase but not during the placebo phase. No increase in creatine kinase was observed in the other subjects. CONCLUSIONS: Itraconazole greatly increases plasma concentrations of lovastatin and lovastatin acid. Inhibition of CYP3A4-mediated metabolism probably explains the increased toxicity of lovastatin caused not only by itraconazole but also by cyclosporine, erythromycin, and other inhibitors of CYP3A4. Their concomitant use with lovastatin and simvastatin should be avoided, or the dose of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors should be reduced accordingly.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0009-9236(96)90167-8

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 24 references

Research works printed but not linked: 5

  1. 1994, Lancet, 344, 1383
  2. Marinella M. A., 1995, West J Med, 162, 176
  3. Smith P. F., 1991, J Pharmacol Exp Ther, 257, 1225
  4. 1991, Therapeutic drugs, vol 2, L66
  5. Vickers S., 1990, Drug Metab Dispos, 18, 476

Cited by

See all 240

Metadata

Authors
Neuvonen, P. J., & Jalava, K.-M.
Affiliations
University of Helsinki (FI)
Corresponding author
Neuvonen, Pertti J.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
1996-07
Volume
60
Issue
1
Pages
54-61
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W1978530024
Cited by
238
References
24
Citations by year
2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 6 · 2016: 3 · 2015: 5 · 2014: 1 · 2013: 6 · 2012: 7
FWCI
20.47
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
itraconazole, lovastatin, drug-drug interactions, CYP3A4 inhibition, statin-induced myopathy, creatine kinase, statins, plasma drug concentration, cyclosporine, erythromycin, simvastatin
MeSH terms
Adult, Anticholesteremic Agents, Antifungal Agents, Cytochrome P-450 Enzyme System, Double-Blind Method, Drug Interactions, Enzyme Inhibitors, Female, Humans, Lovastatin, Male, Itraconazole, Cross-Over Studies, Hydroxymethylglutaryl-CoA Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid. https://app.cochat.ai/papers/10.1016/s0009-9236(96)90167-8
The paper
Neuvonen, P. J., & Jalava, K.-M. (1996). Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid. Clinical Pharmacology & Therapeutics. https://doi.org/10.1016/s0009-9236(96)90167-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.